Congressional negotiators largely back the Pentagon's acquisition overhaul, but are weary of DoD's push for additional budget flexibility.

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

A researcher is planning on investigating potential treatments aimed at the root causes of type 1 diabetes. At the (MUSC), ...

GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...

STORM Therapeutics Ltd. (STORM), the clinical stage company pioneering cellular reprogramming through RNA modifications to treat disease, today announced a strategic collaboration with Alida ...

In the battle against type 1 diabetes (T1D), one researcher at the Medical University of South Carolina (MUSC) is leading a ...

This has been quite the wild year in human evolution stories. Our relatives, living and extinct, got a lot of attention—from new developments in ape cognition to an expanded perspective of a ...

Abstract: In this study, we simulate a 3D Bandgap Engineered (BE-TOX) NAND Flash device using the Monte Carlo method. The simulation considers the Incremental Step Pulse Programming (ISPP) and ...